Koyfin Home > Directory > Health Care > Albireo Pharma Inc > EBITDA / Interest Expenses

Albireo Pharma Inc EBITDA / Interest Expenses Chart (ALBO)

Albireo Pharma Inc annual/quarterly EBITDA / Interest Expenses from 2015 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Albireo Pharma Inc EBITDA / Interest Expenses for the quarter ending June 06, 2020 was $-8m a -111.34% increase of 8m year over year
  • Albireo Pharma Inc EBITDA / Interest Expenses for the last 12 months ending June 06, 2020 was $-11m a -23.80% increase of 3m year over year
  • Albireo Pharma Inc Annual EBITDA / Interest Expenses for 2019 was $-11m a 31.25% decrease of -4m from 2018
  • Albireo Pharma Inc Annual EBITDA / Interest Expenses for 2018 was $-8m a 35.48% decrease of -3m from 2017
  • Albireo Pharma Inc Annual EBITDA / Interest Expenses for 2016 was $-5m a 45.82% decrease of -2m from 2015
Other Ratios Metrics:
  • Albireo Pharma Inc Total Debt / Capital for the quarter ending September 09, 2017 was $2m a -268.92% decrease of -6m year over year
  • Albireo Pharma Inc Other Liabilities for the quarter ending December 12, 2018 was $50m a 8.86% increase of 4m year over year
  • Albireo Pharma Inc Total Debt / Equity for the quarter ending September 09, 2017 was $2m a -291.29% decrease of -6m year over year
View Chart On Koyfin

Quarterly ALBO EBITDA / Interest Expenses Data

06/2020$-8m
03/2020$-15m
12/2019$-7m
09/2019$-16m
06/2019$-11m
03/2019$-12m
12/2018$-18m
09/2018$-9m
06/2018$-6m
03/2018$-1m

Annual ALBO EBITDA / Interest Expenses Data

2019$-11m
2018$-8m
2016$-5m
2015$-3m
2014$-135m